Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 790
Clinical Pharmacology & Biopharmaceutics received 790 citations as per Google Scholar report
Clinical Pharmacology & Biopharmaceutics peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Current trends and procedural outcomes in the era of rotational atherectomy expansion in Poland between 2014-2017 (based on the nationwide ORPKI registry)
Joint Event on 24th World Congress on Pharmacology & 7th World Heart Congress
Rafal Januszek, Zbigniew Siudak, Krzysztof Reczuch, Stefan Dobrzycki, Maciej Lesiak, Jacek Legutko, Pawel Kleczynski, Lukasz Rzeszutko, Dariusz Dudek and Stanisław Bartus
University of Physical Rehabilitation, Poland
Posters & Accepted Abstracts: Clin Pharmacol Biopharm
Abstract
Introduction: The availability of rotational atherectomy (RA) has increased recently in Poland, which was followed by an increase in the rate of RA procedures and catheterization laboratories (CathLabs) performing RA. Aim: To assess current trends regarding the rapid increase in the number of RA procedures and CathLabs performing RA.Material and Methods: We analyzed patients treated with percutaneous coronary intervention (PCI) in the years from 2014 to 2017 available in the nationwide ORPKI dataset. From the overall 431,467 patients treated with PCI, we extracted 1,873 treated with RA. We analyzed the relationship between frequency of RA usage, its distribution between low and high volume centers and procedural outcomes with insight into procedural related complications and procedural effectiveness expressed as target artery patency after PCI
Results: We observed an above threefold increase in the number of RA procedures from 181 in 2014 (0.19%) to 698 in 2017 (0.61%) and an above two fold increase in the number of CathLabs performing RA from 25 (15.5%) in 2014 to 55 (34.1%) in 2017. Besides the fact that patient characteristics have changed in most recent years, the rate of procedural success expressed as procedure related complications has remained stable in the previous following three years and waived around 3%, while the procedural effectiveness expressed as patent target coronary artery after PCI was stable and over 98% in all of the analyzed years.
Conclusions: Apart from the increase the number of RA procedures and CathLabs performing RA, its procedural effectiveness remains at a stable level.
